Product Overview
PT-141 10mg, also known as Bremelanotide, is a high-purity synthetic peptide analog of the naturally occurring α-melanocyte-stimulating hormone (α-MSH). As a potent melanocortin receptor agonist, PT-141 is primarily studied for its influence on the central nervous system (CNS) to modulate sexual arousal, libido, and neuroendocrine regulatory pathways.
Supplied as a 10mg lyophilized (freeze-dried) powder, this research-grade peptide is engineered for maximum stability. Unlike other compounds that target the vascular system, PT-141 is investigated for its unique ability to bypass vascular mechanisms and act directly on the brain’s melanocortin receptors (specifically MC3R and MC4R). Buy PT-141 10mg Wholesale
Mechanism of Action: Central Nervous System Signaling
PT-141 is a cornerstone in neuropeptide research due to its distinct signaling pathway. In laboratory settings, researchers investigate its role in:
- Melanocortin Receptor Activation: Studying how binding to MC3R and MC4R in the hypothalamus triggers arousal and desire.
- Vascular Bypass: Investigating the CNS-driven mechanism that differentiates PT-141 from PDE5 inhibitors, which act solely on blood flow.
- Mind-Body Connection: Researching the integration of emotional intimacy and physiological response in experimental models.
Research Applications
In controlled laboratory environments, PT-141 is utilized for:
- Melanocortin Receptor Signaling Studies: Mapping MC4R-mediated pathways.
- Neuropeptide Regulatory Modeling: Exploring central control of physiological desire.
- Comparative Receptor Agonist Evaluation: Benchmarking PT-141 against Melanotan II or other α-MSH analogs.
- Intracellular Signaling Research: Probing the downstream effects of G-protein coupled receptor activation.
Primary Research Applications Studied Effects
Our PT-141 10mg preparation is frequently utilized in preclinical studies focusing on:
- Sexual Wellness Libido Research
PT-141 is a primary subject in studies involving Hypoactive Sexual Desire Disorder (HSDD) in women and Erectile Dysfunction (ED) in men. Researchers explore its potential to reignite natural desire and enhance sexual interest through neurological pathways. - Performance Anxiety Confidence Models In controlled environments, PT-141 is explored for its potential to lower performance-related anxiety and boost confidence markers in behavioral research models.
- Spontaneity Onset of Action Researchers study the pharmacokinetics of PT-141 to determine its rapid onset of action (often minutes to hours) and its suitability for studying spontaneous physiological responses.
- Combination Therapy Studies Investigating the synergistic effects of PT-141 when studied alongside other treatments, such as Sildenafil or Tadalafil, to evaluate enhanced outcomes in sexual health research.
Reviews
There are no reviews yet.